We are attending BPI Europe 2024
We are pleased to announce our attendance at the upcoming BPI Europe congress, taking place April 9-12 in Vienna.
We’ll be showcasing one of our products for the biomanufacturing industry, our Recombinant Insulin, at booth number 240. Approved by the FDA and EMA, our insulin is a key ingredient in over 100 therapeutic drugs, revolutionizing healthcare worldwide. Don’t miss the chance to learn more about our innovative solutions!
Make sure you join us at booth 240. Looking forward to seeing you there – it’s an opportunity you don’t want to miss!
